159 related articles for article (PubMed ID: 12460961)
1. Lipid-lowering agents and the risk of hip fracture in a Medicaid population.
Ray WA; Daugherty JR; Griffin MR
Inj Prev; 2002 Dec; 8(4):276-9. PubMed ID: 12460961
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
Wang PS; Solomon DH; Mogun H; Avorn J
JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868
[TBL] [Abstract][Full Text] [Related]
3. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
[TBL] [Abstract][Full Text] [Related]
5. Hip fracture risk in statin users--a population-based Danish case-control study.
Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
[TBL] [Abstract][Full Text] [Related]
6. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
[TBL] [Abstract][Full Text] [Related]
7. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
[TBL] [Abstract][Full Text] [Related]
8. Statins and hip fracture prevention--a population based cohort study in women.
Helin-Salmivaara A; Korhonen MJ; Lehenkari P; Junnila SY; Neuvonen PJ; Ruokoniemi P; Huupponen R
PLoS One; 2012; 7(10):e48095. PubMed ID: 23144731
[TBL] [Abstract][Full Text] [Related]
9. Statin use and hip fractures in U.S. kidney transplant recipients.
Vangala C; Lenihan CR; Montez-Rath ME; Nair SS; Navaneethan SD; Ramanathan V; Winkelmayer WC
BMC Nephrol; 2017 May; 18(1):145. PubMed ID: 28460645
[TBL] [Abstract][Full Text] [Related]
10. Statin Use Is Associated With Decreased Osteoporosis and Fracture Risks in Stroke Patients.
Lin SM; Wang JH; Liang CC; Huang HK
J Clin Endocrinol Metab; 2018 Sep; 103(9):3439-3448. PubMed ID: 29982482
[TBL] [Abstract][Full Text] [Related]
11. Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
Seo DH; Jeong Y; Cho Y; Kim SH; Hong S; Suh YJ; Ahn SH
Osteoporos Int; 2023 Nov; 34(11):1927-1936. PubMed ID: 37552294
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitors and the risk of fractures.
Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
Lin TK; Chou P; Lin CH; Hung YJ; Jong GP
PLoS One; 2018; 13(5):e0196713. PubMed ID: 29723231
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis management program decreases incidence of hip fracture in patients with prostate cancer receiving androgen deprivation therapy.
Zhumkhawala AA; Gleason JM; Cheetham TC; Niu F; Loo RK; Dell RM; Jacobsen SJ; Chien GW
Urology; 2013 May; 81(5):1010-5. PubMed ID: 23490521
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
16. Statin use in patients with type 2 diabetes has lower risk of hip fractures: A Taiwan national population-based study.
Lee TC; Chen JC; Lin SY; Ho PS; Chen CH; Fu YC; Chang JK; Ho ML
Diabetes Metab Res Rev; 2023 Mar; 39(3):e3603. PubMed ID: 36579718
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women.
Bakhireva LN; Shainline MR; Carter S; Robinson S; Beaton SJ; Nawarskas JJ; Gunter MJ
Pharmacotherapy; 2010 Sep; 30(9):879-87. PubMed ID: 20795843
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk among statin users: a population-based cohort study.
Friis S; Poulsen AH; Johnsen SP; McLaughlin JK; Fryzek JP; Dalton SO; Sørensen HT; Olsen JH
Int J Cancer; 2005 Apr; 114(4):643-7. PubMed ID: 15578694
[TBL] [Abstract][Full Text] [Related]
19. Use of Statins and Hip Fracture Risk: a Case-Control Study.
Del Chiaro A; Marchetti S; Parchi PD; Caprili G; Ipponi E; Scaglione M
Acta Chir Orthop Traumatol Cech; 2022; 89(2):104-107. PubMed ID: 35621399
[TBL] [Abstract][Full Text] [Related]
20. Use of statins and risk of fractures.
van Staa TP; Wegman S; de Vries F; Leufkens B; Cooper C
JAMA; 2001 Apr; 285(14):1850-5. PubMed ID: 11308398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
